Definium Therapeutics to Participate at Upcoming Investor Conferences
Business Wire•03/11/2026•07:01 ET
0
Key Highlights
- ➤Definium Therapeutics (DFTX) announces participation in four upcoming investor conferences.
- ➤Management will hold fireside chats at Stifel, Jefferies, Evercore, and Piper Sandler conferences.
- ➤Jefferies conference includes a psychedelics panel appearance in London on November 19, 2026.
- ➤Conference events run from November 10 through December 2, 2026.
Definium Therapeutics to Participate at Upcoming Investor Conferences
Definium Therapeutics, Inc. (Nasdaq: DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
Get started
Create a free account to read the full story.